Luis Armando Melendez Serrano

Luis Melendez Serrano practices at Sutter Tracy Community Hospital in Tracy, California, part of Sutter Health.

Luis Melendez Serrano's NPI, 1568877728, was assigned on June 26, 2014. Luis Melendez Serrano holds California license A151303.

Luis Melendez Serrano's primary practice is Sutter Tracy Community Hospital, at 1420 North Tracy Blvd, Tracy, CA 95376 in San Joaquin County. The practice phone is (209) 835-1500.

Luis Melendez Serrano's primary practice is Sutter Tracy Community Hospital in Tracy, California, part of Sutter Health. Luis Melendez Serrano is also affiliated with Dameron Hospital. The medical group on file is Vituity. Dmand AI also links Luis Melendez Serrano to 3 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Luis Melendez Serrano practices, 2 sites in all. Vendor and product names are available with a free account.

Emergency medicine is Luis Melendez Serrano's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dmand AI has Luis Melendez Serrano's licenses on file in 2 states: California and Puerto Rico.

CMS data shows 603 Medicare services from Luis Melendez Serrano across 5 procedure codes in 2024, for 450 Medicare patients. Medicare paid $59,365 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 450 Medicare patients who saw Luis Melendez Serrano in 2024. The largest group is 75 to 84, with 165 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 53% are also on Medicaid. Their average risk score is 2.46, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Luis Melendez Serrano's median patient age at 36, with 56% women.

In 2024, Luis Melendez Serrano wrote 171 Medicare Part D claims for 123 patients. 94% of them were for generic drugs. CMS names the drug for 66 of them, across 4 drugs with 11 or more claims each, at $393 in total drug cost. In 2023, CMS named 74 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Luis Melendez Serrano for performance year 2024, reported as part of a group. Luis Melendez Serrano accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 5 general payments to Luis Melendez Serrano from 4 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $144.